US2023285475A1PendingUtilityA1
Probiotic formulations and methods for use
Assignee: RES INST NATIONWIDE CHILDRENS HOSPITALPriority: Mar 6, 2014Filed: Aug 10, 2022Published: Sep 14, 2023
Est. expiryMar 6, 2034(~7.6 yrs left)· nominal 20-yr term from priority
A23L 33/135A61K 35/747A23V 2200/3202A23V 2200/3204A23L 33/195A23V 2002/00A61P 1/00A61P 1/02A61P 1/04A61P 11/02A61P 15/00A61P 17/00A61P 17/02A61P 25/00A61P 31/04A61P 37/02A61P 43/00A61K 9/1611A61K 9/1647A61K 9/1652A61K 9/1658
82
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are compositions comprising a biocompatible microsphere, a biofilm-generating probiotic bacterium, a prebiotic, and/or a prebiofilmic. Methods for preparing and formulating the compositions and methods for treating or preventing a disease using the compositions are also provided.
Claims
exact text as granted — not AI-modified1 - 61 . (canceled)
62 . A method of treating or alleviating depression or an anxiety disorder in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising Lactobacillus reuteri (“ L. reuteri ”), a biocompatible microsphere, and a water-soluble carbohydrate, thereby treating or alleviating the depression or the anxiety disorder.
63 . The method of claim 62 , wherein the L. reuteri is adhered to the biocompatible microsphere.
64 . The method of claim 62 , wherein the L. reuteri is strain ATCC 23272.
65 . The method of claim 62 , wherein the water-soluble carbohydrate is selected from the group consisting of maltose, sucrose, and combinations thereof.
66 . The method of claim 62 , wherein the biocompatible microsphere has a diameter of about 1 micron to about 100 microns.
67 . The method of claim 62 , wherein the subject also has a gastrointestinal disorder.
68 . The method of claim 62 , wherein administration comprises an oral administration.
69 . The method of claim 62 , wherein the composition is administered to provide from about 1×10 7 to about 1×10 9 CFU/ml of L. reuteri.
70 . The method of claim 62 , wherein the composition is administered in a single dose.
71 . The method of claim 62 , wherein the composition is administered in multiple doses.Join the waitlist — get patent alerts
Track US2023285475A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.